Psoriatic arthritis: hit hard and early
11 June 2025
Laura Coates presents the results from the 'SPEED' trial that found early use of biologic therapy or combination conventional DMARDs may be more effective than standard step-up care with methotrexate for psoriatic arthritis patients with poor prognostic factors.
New CONSORT reporting guidelines published today in five medical journals
15 April 2025
The CONSORT 2025 statement, an updated guideline for reporting randomised trials is being simultaneously published in The BMJ, JAMA, The Lancet, Nature Medicine, and PLOS Medicine.
Blood cancer patients should continue treatment at time of COVID-19 vaccination, OCTRU study shows
9 April 2025
Evidence shows for patients with a type of leukaemia, pausing BTKi therapy for COVID-19 vaccination does not improve antibody responses to the vaccine
TRANSLATE Study Main Results Published
1 April 2025
Results paper published from the TRANSLATE study
SCT's 2025 Class of Fellows announced
28 March 2025
The Society for Clinical Trials (SCT) is an educational, charitable, and scientific organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing all clinical trial professionals. This week the SCT 2025 Class of Fellows was announced and one of OCTRUs current interim directors - Professor Jonathan Cook was listed in that Class - A great accolade. Jonathan will be presented with his award during the SCT 2025 Annual Meeting in Vancouver in May.
SITU announces a trio of new trials
18 June 2024
SITU-NDORMS has announced the launch of three major new clinical trials. Funded by the NIHR, these studies are providing evidence for the treatment of chronic low back pain, knee osteoarthritis, and ACL injuries.